anti-gp100 (aa208-217) TCR, pCDTCR1(TCR-L024Z)
The vector of anti-gp100 T cell receptor (TCR) is constructed for the engineering of T cell to target Human gp100. The T cells are genetically modified through transduction with a retroviral vector expressing gp100-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
Details
Targeting Diseases
Melanoma
Target
Gene Name
premelanosome protein
Synonyms
PMEL; premelanosome protein; SIL, SILV, silver (mouse homolog) like , silver homolog (mouse); melanocyte protein PMEL; D12S53E; gp100; Pmel17; SI; TCR; T cell receptor; transgenic TCR; antigen-specific T cell receptors; Engineering T-cell receptors; recombinant t cell receptors; specific t cell receptor; modified t cell receptor; retroviral vector; Melanoma
Introduction
This gene encodes a melanocyte-specific type I transmembrane glycoprotein. The encoded protein is enriched in melanosomes, which are the melanin-producing organelles in melanocytes, and plays an essential role in the structural organization of premelanosomes. This protein is involved in generating internal matrix fibers that define the transition from Stage I to Stage II melanosomes. This protein undergoes a complex pattern of prosttranslational processing and modification that is essential to the proper functioning of the protein. A secreted form of this protein that is released by proteolytic ectodomain shedding may be used as a melanoma-specific serum marker. Alternate splicing results in multiple transcript variants.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Related Products
| Cat# |
Description |
| TCR-L023 |
Mouse anti-PMEL17 (KTWGQYWQV) T Cell Receptor, pMSGV1 |
| TCR-L030Z |
Human anti-gp100 (aa280-288) T cell receptor (Cysteine-modified TCR), pCDTCR1 |
| TCR-L030 |
Human anti-PMEL17 (YLEPGPVTA) T Cell Receptor, pGMT7 |
| TCR-L031 |
Murinized (from Human) anti-PMEL17 (KTWGQYWQV) T Cell Receptor, pMSGV1 |
| TCR-L029Z |
Human anti-gp100 (aa280-288) T cell receptor (Affinity enhanced), pCDTCR1 |
| TCR-L025Z |
Murinized anti-gp100 (aa208-217) T cell receptor, pCDTCR1 |
| TCR-L027Z |
Human anti-gp100 (aa280-288) T cell receptor, pCDTCR1 |
| TCR-L023Z |
Mouse anti-gp100 (aa154-162) T cell receptor, pCDTCR1 |
| TCR-L029 |
Human anti-PMEL17 (YLEPGPVTA) T Cell Receptor[Affinity Enhanced], pGMT7 |
| TCR-L024 |
Human anti-PMEL17 (IMDQVPFSV) T Cell Receptor, pMSGV1 |
| TCR-L027 |
Human anti-PMEL17 (YLEPGPVTA) T Cell Receptor, pMSGV1 |
| TCR-L025 |
Murinized (from Human) anti-PMEL17 (IMDQVPFSV) T Cell Receptor, pMSGV1 |
| TCR-L028 |
Mouse anti-PMEL17 [154-162] T Cell Receptor, pMSGV1 |
| TCR-L026 |
Murinized (from Human) anti-PMEL17 (IMDQVPFSV) T Cell Receptor[Cysteine-modified], pMSGV1 |
| TCR-L026Z |
Murinized anti-gp100 (aa208-217) T cell receptor (Cysteine-modified), pCDTCR1 |
| TCR-L031Z |
Murinized anti-gp100 (aa154-162) T cell receptor, pCDTCR1 |
Carcinoma
Datasheet
